Microsomal prostaglandin E synthase-1 in rheumatic diseases

Frontiers in Pharmacology

Volumn JAN, Issue , 2011, Pages

  Korotkova, Marina ^a,b   Jakobsson, Per Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Actar AB   (Sweden)

Author keywords

Inflammatory myositis; Inhibitors; Osteoarthritis; Prostaglandin e synthase; Rheumatoid arthritis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOTRIENE RECEPTOR; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN ENDOPEROXIDE; PROSTANOID;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BLOOD CLOTTING; GENE DELETION; HUMAN; IMMUNOHISTOCHEMISTRY; MECHANICAL STIMULATION; MOLECULAR MECHANICS; MOUSE; MYOSITIS; NONHUMAN; OSTEOARTHRITIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RODENT; T LYMPHOCYTE;

EID: 84860309503     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2010.00146     Document Type: Article

References (73)

1. Alvarez-Soria, M. A., Herrero- Beaumont, G., Moreno-Rubio, J., Calvo, E., Santillana, J., Egido, J., and Largo, R. (2008). Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis. Osteoarthr. Cartil. 16, 1484-1493.
2. Amin, A. R., Attur, M., Patel, R. N., Thakker, G. D., Marshall, P. J., Rediske, J., Stuchin, S. A., Patel, I. R., and Abramson, S. B. (1997). Superinduction of cyclooxygenase-2 activity in human osteoarthritis- affected cartilage. Influence of nitric oxide. J. Clin. Invest. 99, 1231-1237.
3. Bruno, A., Di Francesco, L., Coletta, I., Mangano, G., Alisi, M. A., Polenzani, L., Milanese, C., Anzellotti, P., Ricciotti, E., Dovizio, M., Di Francesco, A., Tacconelli, S., Capone, M. L., and Patrignani, P. (2010). Effects of AF3442 [N-(9-ethyl-9H-carbazol-3- yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on pros- tanoid biosynthesis in human mono- cytes in vitro. Biochem. Pharmacol. 79, 974-981.
4. Bucala, R., Ritchlin, C., Winchester, R., and Cerami, A. (1991). Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J. Exp. Med. 173, 569-574.
5. Chan, M. M., and Moore, A. R. (2010). Resolution of inflammation in murine autoimmune arthritis is dis- rupted by cyclooxygenase-2 inhibi- tion and restored by prostaglandin E2-mediated lipoxin A4 production. J. Immunol. 184, 6418-6426.
6. Cheng, S., Afif, H., Martel-Pelletier, J., Pelletier, J. P., Li, X., Farrajota, K., Lavigne, M., and Fahmi, H. (2004). Activation of peroxisome prolif-erator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfer- ing with Egr-1. J. Biol. Chem. 279, 22057-22065.
7. Cheng, Y., Wang, M., Yu, Y., Lawson, J., Funk, C. D., and Fitzgerald, G. A. (2006). Cyclooxygenases, micro- somal prostaglandin E synthase-1, and cardiovascular function. J. Clin. Invest. 116, 1391-1399.
8. Claveau, D., Sirinyan, M., Guay, J., Gordon, R., Chan, C. C., Bureau, Y., Riendeau, D., and Mancini, J. A. (2003). Microsomal prostaglandin E synthase-1 is a major terminal syn- thase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model. J. Immunol. 170, 4738-4744.
9. Degousee, N., Fazel, S., Angoulvant, D., Stefanski, E., Pawelzik, S. C., Korotkova, M., Arab, S., Liu, P., Lindsay, T. F., Zhuo, S., Butany, J., Li, R. K., Audoly, L., Schmidt, R., Angioni, C., Geisslinger, G., Jakobsson, P. J., and Rubin, B. B. (2008). Microsomal pros- taglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction. Circulation 117, 1701-1710.
10. DeGroot, J., Verzijl, N., Wenting-van Wijk, M. J., Jacobs, K. M., Van El, B., Van Roermund, P. M., Bank, R. A., Bijlsma, J. W., TeKoppele, J. M., and Lafeber, F. P. (2004). Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum. 50, 1207-1215.
11. Dieter, P., Scheibe, R., Jakobsson, P. J., Watanabe, K., Kolada, A., and Kamionka, S. (2000). Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages. Biochem. Biophys. Res. Commun. 276, 488-492.
12. Distler, J. H., Pisetsky, D. S., Huber, L. C., Kalden, J. R., Gay, S., and Distler, O. (2005). Microparticles as regulators of inflammation: novel players of cellu- lar crosstalk in the rheumatic diseases. Arthritis Rheum. 52, 3337-3348.
13. Ehling, A., Schaffler, A., Herfarth, H., Tarner, I. H., Anders, S., Distler, O., Paul, G., Distler, J., Gay, S., Scholmerich, J., Neumann, E., and Muller-Ladner, U. (2006). The potential of adiponectin in driving arthritis. J. Immunol. 176, 4468-4478.
14. Engblom, D., Ek, M., Andersson, I. M., Saha, S., Dahlstrom, M., Jakobsson, P. J., Ericsson-Dahlstrand, A., and Blomqvist, A. (2002). Induction of microsomal prostaglandin E synthase in the rat brain endothelium and parenchyma in adjuvant- induced arthritis. J. Comp. Neurol. 452, 205-214.
15. Engblom, D., Ek, M., Saha, S., Ericsson- Dahlstrand, A., Jakobsson, P. J., and Blomqvist, A. (2002). Prostaglandins as inflammatory messengers across the blood-brain barrier. J. Mol. Med. 80, 5-15.
16. Engblom, D., Saha, S., Engstrom, L., Westman, M., Audoly, L. P., Jakobsson, P. J., and Blomqvist, A. (2003). Microsomal prostaglandin E synthase-1 is the central switch dur- ing immune-induced pyresis. Nat. Neurosci. 6, 1137-1138.
17. Facemire, C. S., Griffiths, R., Audoly, L. P., Koller, B. H., and Coffman, T. M. (2010). The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic back- ground. Hypertension 55, 531-538.
18. Faour, W. H., He, Y., He, Q. W., de Ladurantaye, M., Quintero, M., Mancini, A., and Di Battista, J. A. (2001). Prostaglandin E(2) regulates the level and stability of cyclooxyge- nase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts. J. Biol. Chem. 276, 31720-31731.
19. Francois, H., Facemire, C., Kumar, A., Audoly, L., Koller, B., and Coffman, T. (2007). Role of microsomal prostag- landin E synthase 1 in the kidney. J. Am. Soc. Nephrol. 18, 1466-1475.
20. Gomez, P. F., Pillinger, M. H., Attur, M., Marjanovic, N., Dave, M., Park, J., Bingham, C. O. III, Al-Mussawir, H., and Abramson, S. B. (2005). Resolution of inflammation: prostag- landin E2 dissociates nuclear traffick- ing of individual NF-kappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts. J. Immunol. 175, 6924-6930.
21. Gosset, M., Berenbaum, F., Levy, A., Pigenet, A., Thirion, S., Saffar, J. L., and Jacques, C. (2006). Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mech- anosensitive gene. Arthritis Res. Ther. 8, R135.
22. Gosset, M., Berenbaum, F., Salvat, C., Sautet, A., Pigenet, A., Tahiri, K., and Jacques, C. (2008). Crucial role of visfa- tin/pre-B cell colony-enhancing factor in matrix degradation and prostag- landin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum. 58, 1399-1409.
23. Grimmer, C., Pfander, D., Swoboda, B., Aigner, T., Mueller, L., Hennig, F. F., and Gelse, K. (2007). Hypoxia- inducible factor 1alpha is involved in the prostaglandin metabolism of osteoarthritic cartilage through up- regulation of microsomal pros- taglandin E synthase 1 in articular chondrocytes. Arthritis Rheum. 56, 4084-4094.
24. Guerrero, M. D., Aquino, M., Bruno, I., Riccio, R., Terencio, M. C., and Paya, M. (2009). Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E syn- thase-1 expression. Eur. J. Pharmacol. 620, 112-119.
25. Guerrero, M. D., Aquino, M., Bruno, I., Terencio, M. C., Paya, M., Riccio, R., and Gomez-Paloma, L. (2007). Synthesis and pharmacological eval- uation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybuteno- lide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expres- sion. J. Med. Chem. 50, 2176-2184.
26. Hulkower, K. I., Wertheimer, S. J., Levin, W., Coffey, J. W., Anderson, C. M., Chen, T., DeWitt, D. L., Crowl, R. M., Hope, W. C., and Morgan, D. W. (1994). Interleukin-1 beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Evidence for their roles in the production of prostaglandin E2. Arthritis Rheum. 37, 653-661.
27. Inada, M., Matsumoto, C., Uematsu, S., Akira, S., and Miyaura, C. (2006). Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a criti- cal role in lipopolysaccharide-induced bone loss associated with inflamma- tion. J. Immunol. 177, 1879-1885.
28. Jakobsson, P. J., Thoren, S., Morgenstern, R., and Samuelsson, B. (1999). Identification of human prostaglan- din E synthase: a microsomal, glutath- ione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. U.S.A. 96, 7220-7225.
29. Jegerschold, C., Pawelzik, S. C., Purhonen, P., Bhakat, P., Gheorghe, K. R., Gyobu, N., Mitsuoka, K., Morgenstern, R., Jakobsson, P. J., and Hebert, H. (2008). Structural basis for induced formation of the inflammatory mediator pros- taglandin E2. Proc. Natl. Acad. Sci. U.S.A. 105, 11110-11115.
30. Jia, Z., Guo, X., Zhang, H., Wang, M. H., Dong, Z., and Yang, T. (2008). Microsomal prostaglandin synthase- 1-derived prostaglandin E2 protects against angiotensin II-induced hyper- tension via inhibition of oxidative stress. Hypertension 52, 952-959.
31. Jia, Z., Zhang, A., Zhang, H., Dong, Z., and Yang, T. (2006). Deletion of micro- somal prostaglandin E synthase-1 increases sensitivity to salt loading and angiotensin II infusion. Circ. Res. 99, 1243-1251.
32. Jungel, A., Distler, O., Schulze-Horsel, U., Huber, L. C., Ha, H. R., Simmen, B., Kalden, J. R., Pisetsky, D. S., Gay, S., and Distler, J. H. (2007). Microparticles stimulate the synthesis of prostaglan- din E(2) via induction of cyclooxyge- nase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum. 56, 3564-3574.
33. Kamei, D., Yamakawa, K., Takegoshi, Y., Mikami-Nakanishi, M., Nakatani, Y., Oh-Ishi, S., Yasui, H., Azuma, Y., Hirasawa, N., Ohuchi, K., Kawaguchi, H., Ishikawa, Y., Ishii, T., Uematsu, S., Akira, S., Murakami, M., and Kudo, I. (2004). Reduced pain hypersensitiv- ity and inflammation in mice lacking microsomal prostaglandin e synthase-1. J. Biol. Chem. 279, 33684-33695.
34. Kapoor, M., Kojima, F., Yang, L., and Crofford, L. J. (2007). Sequential induction of pro- and anti-inflam- matory prostaglandins and per- oxisome proliferators-activated receptor-gamma during normal wound healing: a time course study. Prostaglandins Leukot. Essent. Fatty Acids 76, 103-112.
35. Kojima, F., Kapoor, M., Yang, L., Fleishaker, E. L., Ward, M. R., Monrad, S. U., Kottangada, P. C., Pace, C. Q., Clark, J. A., Woodward, J. G., and Crofford, L. J. (2008). Defective generation of a humoral immune response is associ- ated with a reduced incidence and severity of collagen-induced arthritis in microsomal prostaglandin E syn- thase-1 null mice. J. Immunol. 180, 8361-8368.
36. Kojima, F., Kato, S., and Kawai, S. (2005). Prostaglandin E synthase in the patho- physiology of arthritis. Fundam. Clin. Pharmacol. 19, 255-261.
37. Kojima, F., Naraba, H., Miyamoto, S., Beppu, M., Aoki, H., and Kawai, S. (2004). Membrane-associated pros- taglandin E synthase-1 is upregu- lated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. Arthritis Res. Ther. 6, R355-R365.
38. Kojima, F., Naraba, H., Sasaki, Y., Beppu, M., Aoki, H., and Kawai, S. (2003). Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibrob- lasts. Arthritis Rheum. 48, 2819-2828.
39. Kojima, F., Naraba, H., Sasaki, Y., Okamoto, R., Koshino, T., and Kawai, S. (2002). Coexpression of microsomal prostag- landin E synthase with cyclooxygen- ase-2 in human rheumatoid synovial cells. J. Rheumatol. 29, 1836-1842.
40. Korotkova, M., Helmers, S. B., Loell, I., Alexanderson, H., Grundtman, C., Dorph, C., Lundberg, I. E., and Jakobsson, P. J. (2008). Effects of immunosuppressive treatment on microsomal prostaglandin E syn- thase 1 and cyclooxygenases expres- sion in muscle tissue of patients with polymyositis or dermatomyositis. Ann. Rheum. Dis. 67, 1596-1602.
41. Korotkova, M., Westman, M., Gheorghe, K. R., af Klint, E., Trollmo, C., Ulfgren, A. K., Klareskog, L., and Jakobsson, P. J. (2005). Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway. Arthritis Rheum. 52, 3439-3447.
42. Kusada, J., Otsuka, T., Matsui, N., Hirano, T., Asai, K., and Kato, T. (1993). Immuno-reactive human epidermal growth factor (h-EGF) in rheumatoid synovial fluids. Nippon Seikeigeka Gakkai Zasshi 67, 859-865.
43. Kusunoki, N., Kitahara, K., Kojima, F., Tanaka, N., Kaneko, K., Endo, H., Suguro, T., and Kawai, S. (2010). Adiponectin stimulates prostaglan- din E(2) production in rheumatoid synovial fibroblasts. Arthritis Rheum. 62, 1641-1649.
44. Lazarus, M., Kubata, B. K., Eguchi, N., Fujitani, Y., Urade, Y., and Hayaishi, O. (2002). Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages. Arch. Biochem. Biophys. 397, 336-341.
45. Li, X., Afif, H., Cheng, S., Martel-Pelletier, J., Pelletier, J. P., Ranger, P., and Fahmi, H. (2005). Expression and regula- tion of microsomal prostaglandin E synthase-1 in human osteoar- thritic cartilage and chondrocytes. J. Rheumatol. 32, 887-895.
46. Mancini, J. A., Blood, K., Guay, J., Gordon, R., Claveau, D., Chan, C. C., and Riendeau, D. (2001). Cloning, expres- sion, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis. J. Biol. Chem. 276, 4469-4475.
47. Masuko-Hongo, K., Berenbaum, F., Humbert, L., Salvat, C., Goldring, M. B., and Thirion, S. (2004). Up-regulation of microsomal pros- taglandin E synthase 1 in osteoar-thritic human cartilage: critical roles of the ERK-1/2 and p38 sign- aling pathways. Arthritis Rheum. 50, 2829-2838.
48. Mbalaviele, G., Pauley, A. M., Shaffer, A. F., Zweifel, B. S., Mathialagan, S., Mnich, S. J., Nemirovskiy, O. V., Carter, J., Gierse, J. K., Wang, J. L., Vazquez, M. L., Moore, W. M., and Masferrer, J. L. (2010). Distinction of microsomal prostaglandin E syn- thase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor. Biochem. Pharmacol. 79, 1445-1454.
49. Murakami, M., Nakashima, K., Kamei, D., Masuda, S., Ishikawa, Y., Ishii, T., Ohmiya, Y., Watanabe, K., and Kudo, I. (2003). Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J. Biol. Chem. 278, 37937-37947.
50. Murakami, M., Nakatani, Y., Tanioka, T., and Kudo, I. (2002). Prostaglandin E synthase. Prostaglandins Other Lipid Mediat. 68-69, 383-399.
51. Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Oh, S., and Kudo, I. (2000). Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792.
52. Nah, S. S., Choi, I. Y., Lee, C. K., Oh, J. S., Kim, Y. G., Moon, H. B., and Yoo, B. (2008). Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human oste- oarthritic chondrocytes. Rheumatology (Oxford) 47, 425-431.
53. Nah, S. S., Won, H. J., Ha, E., Kang, I., Cho, H. Y., Hur, S. J., Lee, S. H., and Baik, H. H. (2010). Epidermal growth factor increases prostaglandin E2 production via ERK1/2 MAPK and NF-kappaB pathway in fibroblast like synoviocytes from patients with rheumatoid arthritis. Rheumatol. Int. 30, 443-449.
54. Naraba, H., Yokoyama, C., Tago, N., Murakami, M., Kudo, I., Fueki, M., Oh-Ishi, S., and Tanabe, T. (2002). Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J. Biol. Chem. 277, 28601-28608.
55. Newton, R., Seybold, J., Kuitert, L. M., Bergmann, M., and Barnes, P. J. (1998). Repression of cyclooxygen- ase-2 and prostaglandin E2 release by dexamethasone occurs by tran- scriptional and post-transcriptional mechanisms involving loss of polya- denylated mRNA. J. Biol. Chem. 273, 32312-32321.
56. Pawelzik, S. C., Uda, N. R., Spahiu, L., Jegerschold, C., Stenberg, P., Hebert, H., Morgenstern, R., and Jakobsson, P. J. (2010). Identification of key resi- dues determining species differences in inhibitor binding of microsomal prostaglandin E synthase-1. J. Biol. Chem. 285, 29254-29261.
57. Pettersson, P. L., Thoren, S., and Jakobsson, P. J. (2005). Human microsomal prostaglandin E syn- thase 1: a member of the MAPEG protein superfamily. Meth. Enzymol. 401, 147-161.
58. Pottie, P., Presle, N., Terlain, B., Netter, P., Mainard, D., and Berenbaum, F. (2006). Obesity and osteoarthritis: more complex than predicted! Ann. Rheum. Dis. 65, 1403-1405.
59. Punzi, L., Schiavon, F., Cavasin, F., Ramonda, R., Gambari, P. F., and Todesco, S. (1989). The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid. Clin. Exp. Rheumatol. 7, 247-250.
60. Saegusa, M., Murakami, M., Nakatani, Y., Yamakawa, K., Katagiri, M., Matsuda, K., Nakamura, K., Kudo, I., and Kawaguchi, H. (2003). Contribution of membrane-associated prostaglan- din E2 synthase to bone resorption. J. Cell. Physiol. 197, 348-356.
61. Samuelsson, B., Morgenstern, R., and Jakobsson, P. J. (2007). Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol. Rev. 59, 207-224.
62. Satoh, K., Kikuchi, S., Sekimata, M., Kabuyama, Y., Homma, M. K., and Homma, Y. (2001). Involvement of ErbB-2 in rheumatoid synovial cell growth. Arthritis Rheum. 44, 260-265.
63. Shimpo, H., Sakai, T., Kondo, S., Mishima, S., Yoda, M., Hiraiwa, H., and Ishiguro, N. (2009). Regulation of prostaglan- din E(2) synthesis in cells derived from chondrocytes of patients with osteoarthritis. J. Orthop. Sci. 14, 611-617.
64. Stichtenoth, D. O., Thoren, S., Bian, H., Peters-Golden, M., Jakobsson, P. J., and Crofford, L. J. (2001). Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheuma- toid synovial cells. J. Immunol. 167, 469-474.
65. Tai, N., Kuwabara, K., Kobayashi, M., Yamada, K., Ono, T., Seno, K., Gahara, Y., Ishizaki, J., and Hori, Y. (2010). Cytosolic phospholipase A2 alpha inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destruc- tive action in a murine arthritis model. Inflamm. Res. 59, 53-62.
66. Tanioka, T., Nakatani, Y., Kobayashi, T., Tsujimoto, M., Oh-ishi, S., Murakami, M., and Kudo, I. (2003). Regulation of cytosolic prostaglandin E2 syn- thase by 90-kDa heat shock protein. Biochem. Biophys. Res. Commun. 303, 1018-1023.
67. Thoren, S., and Jakobsson, P. J. (2000). Coordinate up- and down-regulation of glutathione-dependent prostaglan- din E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. Eur. J. Biochem. 267, 6428-6434.
68. Trebino, C. E., Stock, J. L., Gibbons, C. P., Naiman, B. M., Wachtmann, T. S., Umland, J. P., Pandher, K., Lapointe, J. M., Saha, S., Roach, M. L., Carter, D., Thomas, N. A., Durtschi, B. A., McNeish, J. D., Hambor, J. E., Jakobsson, P. J., Carty, T. J., Perez, J. R., and Audoly, L. P. (2003). Impaired inflammatory and pain responses in mice lacking an inducible prostaglan- din E synthase. Proc. Natl. Acad. Sci. U.S.A. 100, 9044-9049.
69. Wang, M., Song, W. L., Cheng, Y., and Fitzgerald, G. A. (2008). Microsomal prostaglandin E synthase-1 inhibi- tion in cardiovascular inflamma- tory disease. J. Intern. Med. 263, 500-505.
70. Wang, M., Zukas, A. M., Hui, Y., Ricciotti, E., Pure, E., and FitzGerald, G. A. (2006). Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogene- sis. Proc. Natl. Acad. Sci. U.S.A. 103, 14507-14512.
71. Westman, M., Korotkova, M., af Klint, E., Stark, A., Audoly, L. P., Klareskog, L., Ulfgren, A. K., and Jakobsson, P. J. (2004). Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium. Arthritis Rheum. 50, 1774-1780.
72. Wu, D., Mennerich, D., Arndt, K., Sugiyama, K., Ozaki, N., Schwarz, K., Wei, J., Wu, H., Bishopric, N. H., and Doods, H. (2009). Comparison of microsomal prostaglandin E syn- thase-1 deletion and COX-2 inhibi- tion in acute cardiac ischemia in mice. Prostaglandins Other Lipid Mediat. 90, 21-25.
73. Xu, D., Rowland, S. E., Clark, P., Giroux, A., Cote, B., Guiral, S., Salem, M., Ducharme, Y., Friesen, R. W., Methot, N., Mancini, J., Audoly, L., and Riendeau, D. (2008). MF63 [2-(6- chloro-1H-phenanthro[9,10-d] imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyre- sis and pain in preclinical models of inflammation. J. Pharmacol. Exp. Ther. 326, 754-763.